Lenalidomid Zentiva 5 mg, Hartkapseln - 21 Swissmedic Key 67850002 Registration Holder Helvepharm AG Name Lenalidomid Zentiva 5 mg, Hartkapseln Date of registration 29.10.2020 Original/Generic Generic Introduction of Sequence 29.10.2020 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until 28.10.2025 Index Therapeuticus (BSV) 07.16.10. Show package size 21 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 707.76 Limitation Yes Limitation text
Deductible 10 % Consumer price 786.15 Feedback FB Daily cost GTIN 7680678500021 Medication Code Synthetika Pharmacode Disponibility
Composition lenalidomidum 5 mg, cellulosum microcristallinum, lactosum 66.4 mg, carmellosum natricum conexum corresp. natrium 0.178 mg, magnesii stearas, Kapselhülle: gelatina, titanii dioxidum, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. Packungsbestandteile Galenic Form Capsules Active Agent Dose Lenalidomidum 5 mg
BAG: Active Agent Dose Lenalidomidum 5 mg
Inactive agents Dose additional_information (Nigrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 172 color. Gelatina Kapselhülle Kalii Hydroxidum Lacca Drucktinte Lactosum 66.4 mg Magnesii Stearas Pro Capsula Propylenglycol Titanium Dioxide
Source Data was imported : 06.11.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
